|1.||Lin, Hui-Yi: 5 articles (05/2015 - 08/2012)|
|2.||Hsu, Shu-Chun: 3 articles (05/2015 - 01/2015)|
|3.||Hsu, Wu-Huei: 3 articles (05/2015 - 01/2015)|
|4.||Liu, Hsin-Chung: 3 articles (05/2015 - 01/2015)|
|5.||Ko, Yang-Ching: 3 articles (05/2015 - 01/2015)|
|6.||Chung, Jing-Gung: 3 articles (05/2015 - 01/2015)|
|7.||Limtrakul, Pornngarm: 3 articles (02/2010 - 04/2004)|
|8.||Shi, Lei: 2 articles (12/2015 - 08/2015)|
|9.||Ji, Bin-Chuan: 2 articles (05/2015 - 05/2015)|
|10.||Yang, Mei-Due: 2 articles (05/2015 - 05/2015)|
01/28/2015 - "These results suggested that demethoxycurcumin may be a potential additive natural product in combination with chemotherapeutic agents in drug-resistant cancers. "
01/01/2013 - "Concurrent inhibition of enzymatic activity and NF-Y-mediated transcription of Topoisomerase-IIα by bis-DemethoxyCurcumin in cancer cells."
05/01/2015 - "Demethoxycurcumin (DMC) is a key component of Chinese medicine (Turmeric) and has been proven effective in killing various cancer cells. "
04/06/2015 - "Demethoxycurcumin-carrying chitosan-antibody core-shell nanoparticles with multitherapeutic efficacy toward malignant A549 lung tumor: from in vitro characterization to in vivo evaluation."
01/01/2015 - "Demethoxycurcumin (DMC) has been shown to exert cytotoxic effects in human cancer cells via induction of apoptosis. "
|2.||Alzheimer Disease (Alzheimer's Disease)
02/01/2009 - "Curcuminoids (a mixture of curcumin, bisdemethoxycurcumin and demethoxycurcumin) share vital pharmacological properties possessed by turmeric, a well known curry spice, considered useful in Alzheimer's disease (AD). "
12/01/2012 - "Effects of curcumin and demethoxycurcumin on amyloid-β precursor and tau proteins through the internal ribosome entry sites: a potential therapeutic for Alzheimer's disease."
12/01/2012 - "This study aims to determine the effects of curcumin and demethoxycurcumin on the internal ribosome entry site of the amyloid-β precursor protein (APP) and tau protein through a bi-cistronic reporter assay for screening of anti-Alzheimer's disease agents. "
|3.||Body Weight (Weight, Body)
12/01/2013 - "Pretreatment with polymeric N-isopropyl acryl amide (PNIPAM) nanoparticles formulation of all three curcuminoids (curcumin (Cur), demethoxycurcumin (DMC), and bisdemethoxycurcumin (BDMC)) at doses (100 μg/kg body weight) given intranasally was effective in bringing significant changes on all the parameters. "
01/01/2012 - "Demethoxycurcumin Retards Cell Growth and Induces Apoptosis in Human Brain Malignant Glioma GBM 8401 Cells."
07/10/2009 - "Demethoxycurcumin induces Bcl-2 mediated G2/M arrest and apoptosis in human glioma U87 cells."
12/01/2015 - "In this study, we found low-dose demethoxycurcumin (DMC) could enhance the sensitivity of TMZ on glioma cells, and high-dose DMC has more significant effects on GBM cells compared with TMZ treatment alone both in vitro and in vivo. "
08/01/2015 - "Recently, demethoxycurcumin (DMC) has been shown to display anti-tumor activities in malignant gliomas. "
04/01/2008 - "Taken together, all of the results showed that the suppressive effect of demethoxycurcumin was stronger than that of bisdemethoxycurcumin, indicating that the methoxy group had enhanced demethoxycurcumin's anti-inflammation effects."
10/01/1995 - "In additional studies we found that commercial grade curcumin, pure curcumin, demethoxycurcumin and bisdemethoxycurcumin had about the same potent inhibitory effect on TPA-induced inflammation of mouse ears, as well as TPA-induced transformation of cultured JB6 (P+) cells. "
|4.||tau Proteins (tau Protein)
|5.||Amyloid (Amyloid Fibrils)
|8.||Ornithine Decarboxylase (Decarboxylase, Ornithine)